Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-01-06 @ 5:37 AM
Study NCT ID:
NCT01586195
Status:
TERMINATED
Last Update Posted:
2017-05-25
First Post:
2012-04-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-24
First Submit QC Date:
None
Study First Post Date:
2012-04-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-07
Results First Submit QC Date:
None
Results First Post Date:
2017-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-24
Last Update Post Date:
2017-05-25
Last Update Post Date Type:
ACTUAL